{
    "id": 26899,
    "fullName": "TP53 Y163*",
    "impact": "nonsense",
    "proteinEffect": "loss of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "TP53 Y163* results in a premature truncation of the Tp53 protein at amino acid 163 of 393 (UniProt.org). Due to the loss of several functional domains (UniProt.org), Y163* is predicted to lead to a loss of Tp53 protein function.",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 7157,
        "geneSymbol": "TP53",
        "terms": [
            "TP53",
            "BCC7",
            "BMFS5",
            "LFS1",
            "P53",
            "TRP53"
        ]
    },
    "variant": "Y163*",
    "createDate": "08/22/2017",
    "updateDate": "08/22/2017",
    "referenceTranscriptCoordinates": {
        "id": 95939,
        "transcript": "NM_000546",
        "gDna": "chr17:g.7675123G>T",
        "cDna": "c.489C>A",
        "protein": "p.Y163*",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 11782,
            "approvalStatus": "Phase II",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a Phase II trial, Paraplatin (carboplatin) and Adavosertib (MK-1775) combination treatment resulted in partial response in an ovarian cancer patient harboring TP53 Y163* (PMID: 27998224).",
            "molecularProfile": {
                "id": 28224,
                "profileName": "TP53 Y163*"
            },
            "therapy": {
                "id": 1194,
                "therapyName": "Adavosertib + Carboplatin",
                "synonyms": null
            },
            "indication": {
                "id": 2394,
                "name": "ovarian cancer",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 9762,
                    "pubMedId": 27998224,
                    "title": "Phase II Study of WEE1 Inhibitor AZD1775 Plus Carboplatin in Patients With TP53-Mutated Ovarian Cancer Refractory or Resistant to First-Line Therapy Within 3 Months.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27998224"
                }
            ],
            "ampCapAscoEvidenceLevel": "B",
            "ampCapAscoInferredTier": "I"
        }
    ],
    "molecularProfiles": [
        {
            "id": 28224,
            "profileName": "TP53 Y163*",
            "profileTreatmentApproaches": [
                {
                    "id": 14691,
                    "name": "p53 Gene Therapy",
                    "profileName": "TP53 Y163*"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 95941,
            "transcript": "NM_001126114",
            "gDna": "chr17:g.7675123G>T",
            "cDna": "c.489C>A",
            "protein": "p.Y163*",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 95940,
            "transcript": "NM_001126113",
            "gDna": "chr17:g.7675123G>T",
            "cDna": "c.489C>A",
            "protein": "p.Y163*",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 95938,
            "transcript": "NM_001126112",
            "gDna": "chr17:g.7675123G>T",
            "cDna": "c.489C>A",
            "protein": "p.Y163*",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 95939,
            "transcript": "NM_000546",
            "gDna": "chr17:g.7675123G>T",
            "cDna": "c.489C>A",
            "protein": "p.Y163*",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}